Novo Nordisk  

Using Insulin Effectively

Rapid-acting insulin analogue regimens

Anticipate different diurnal profiles of blood glucose control and hypoglycaemia than for human insulin, and thus a need for different dose regimens and different monitoring schemes

Give
careful attention to these details, as any improvement in glycated haemoglobin concentration will be dependent on this
Make the following changes when using rapid-acting analogues compared to unmodified human insulin :

monitor the effect of a short-acting analogue post-prandially ( at 1-2 h ), and always less than 4 h after injection

expect to use lower pre-meal insulin doses than with human insulin

use combined NPH + analogue injection before meals, if the between-meal interval is to be greater than 5 h

use a higher late-evening NPH dose ( unless the aim is specifically to deal with a problem of night-time hypoglycaemia )

use late-evening NPH no longer than 4 h after the evening analogue injection
Our knowledge of the optimal use of rapid-acting ( and new long-acting ) analogues is evolving month by month – we anticipate a need to modify this advice early on

 

Using Insulin Effectively -
Insulin dose adjustment

 

IDF Guidelines to Type 1 diabetes
Click here for 'Topic Finder'

Click here for 'Ensure effective delivery of care'
Click here for 'Promote effective self-care'
Control blood glucose, blood lipids, arterial factors
Assessing Blood Glucose Control
Providing Eating and Drinking Advice
Physical Exercise
Using Insulin Effectively
- Insulin, injections, and associated education
- Insulin dose requirements - general considerations
- Rapid-acting insulin analogue regimens
- Insulin dose adjustment
Hypoglycameia Problems
Managing Arterial Risk Factors and Ischaemic heart Disease
Click here for 'Detect and manage diabetes complications'
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page